Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation

Abstract

Description

Keywords

Covid-19, Europe, Hematopoietic stem cell transplantation, Humans, Leukemia, Leukemia, myeloid, acute, Pandemics, Precursor cell lymphoblastic leukemia-lymphoma, Risk factors, Sars-cov-2, Societies, medical, Tissue and organ procurement, Arsenic trioxide, Blinatumomab, Cytarabine, Glucocorticoid, Idarubicin, Inotuzumab ozogamicin, Retinoic acid, Sars-cov-2 vaccine, Acute leukemia, Acute lymphoblastic leukemia, Acute myeloid leukemia, Article, Bone marrow transplantation, Cancer screening, Cancer survival, Clinical practice, Coronavirus disease 2019, Cytogenetics, Human, Intensive care unit, Medical society, Minimal residual disease, Molecular biology, Mortality rate, Overall survival, Practice guideline, Risk assessment, Risk factor, Stem cell transplantation, Telemedicine, Complication, Epidemiology, Pandemic, Transplantation

Citation

Endorsement

Review

Supplemented By

Referenced By